These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 23469253)

  • 1. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
    Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
    PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.
    Choudhury KR; Das S; Bhattacharyya NP
    J Proteomics; 2016 Jan; 132():155-66. PubMed ID: 26581643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
    Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
    J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease.
    Wang Q; Liang G; Yang H; Wang S; Eckenhoff MF; Wei H
    Toxicol Appl Pharmacol; 2011 Feb; 250(3):291-8. PubMed ID: 21059370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.
    Kong PJ; Kil MO; Lee H; Kim SS; Johnson GV; Chun W
    Neurol Res; 2009 Feb; 31(1):77-83. PubMed ID: 18691453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice.
    Frederick NM; Bertho J; Patel KK; Petr GT; Bakradze E; Smith SB; Rosenberg PA
    Neurochem Int; 2014 Oct; 76():59-69. PubMed ID: 25004085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
    Wang H; Lim PJ; Karbowski M; Monteiro MJ
    Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease.
    Quintanilla RA; Jin YN; Fuenzalida K; Bronfman M; Johnson GVW
    J Biol Chem; 2008 Sep; 283(37):25628-25637. PubMed ID: 18640979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease.
    Siddiqui A; Rivera-Sánchez S; Castro Mdel R; Acevedo-Torres K; Rane A; Torres-Ramos CA; Nicholls DG; Andersen JK; Ayala-Torres S
    Free Radic Biol Med; 2012 Oct; 53(7):1478-88. PubMed ID: 22709585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.
    Xifró X; Anglada-Huguet M; Rué L; Saavedra A; Pérez-Navarro E; Alberch J
    Mol Neurodegener; 2011 Oct; 6():74. PubMed ID: 22041125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease.
    Ghose J; Sinha M; Das E; Jana NR; Bhattacharyya NP
    PLoS One; 2011; 6(8):e23837. PubMed ID: 21887328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ.
    Jin YN; Hwang WY; Jo C; Johnson GV
    PLoS One; 2012; 7(1):e30406. PubMed ID: 22276192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q111)/Hdh(Q111) cells.
    Das E; Jana NR; Bhattacharyya NP
    Biochem Biophys Res Commun; 2013 Jul; 437(2):217-24. PubMed ID: 23796713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's disease.
    Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Yang SH
    Free Radic Biol Med; 2019 Jan; 130():256-266. PubMed ID: 30391672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twist1 Plays an Anti-apoptotic Role in Mutant Huntingtin Expression Striatal Progenitor Cells.
    Jen WP; Chen HM; Lin YS; Chern Y; Lee YC
    Mol Neurobiol; 2020 Mar; 57(3):1688-1703. PubMed ID: 31813126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP.
    Sinha M; Ghose J; Das E; Bhattarcharyya NP
    Biochem Biophys Res Commun; 2010 Jun; 396(3):742-7. PubMed ID: 20451497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleuropein enhances proteasomal activity and reduces mutant huntingtin-induced cytotoxicity.
    Huang ZN; Lee SY; Chen JM; Huang ZT; Her LS
    Front Pharmacol; 2024; 15():1459909. PubMed ID: 39351099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.
    Kim J; Moody JP; Edgerly CK; Bordiuk OL; Cormier K; Smith K; Beal MF; Ferrante RJ
    Hum Mol Genet; 2010 Oct; 19(20):3919-35. PubMed ID: 20660112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells.
    Oliveira AM; Cardoso SM; Ribeiro M; Seixas RS; Silva AM; Rego AC
    Neurochem Int; 2015 Dec; 91():1-12. PubMed ID: 26476055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.
    Shirendeb U; Reddy AP; Manczak M; Calkins MJ; Mao P; Tagle DA; Reddy PH
    Hum Mol Genet; 2011 Apr; 20(7):1438-55. PubMed ID: 21257639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.